PEREZ, L. Agueda  and  POR EL GRUPO DE TRABAJO EN CISTICERCOSIS EN PERU: OTROS MIEMBROS INCLUYEN: ROBERT H. GILMAN, MD, DTMH; ARMANDO E. GONZALEZ, DVM, PHD; Y VICTOR C.W. TSANG, PHD (COORDINATION BOARD); SILVIA RODRIGUEZ, MSC; ISIDRO GONZALEZ, MD; HERBERT SAAVEDRA, MD; SOFIA SANCHEZ, MD; MANUEL MARTINEZ, MD (INSTITUTO NACIONAL DE CIENCIAS NEUROLOGICAS, LIMA, PERU); MANUELA VERASTEGUI, PHD; MIRKO ZIMIC, PHD; SAUL SANTIVANEZ, MD, PHD; HOLGER MAYTA, PHD; MONICA PAJUELO, PHD; GIANFRANCO ARROYO, DVM, MSC (UNIVERSIDAD PERUANA CAYETANO HEREDIA, LIMA, PERU); MARIA T. LOPEZ, DVM, PHD; LUIS GOMEZ, DVM; ANA VARGAS, DVM; CESAR M. GAVIDIA, DVM, PHD (SCHOOL OF VETERINARY MEDICINE, UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS, LIMA, PERU); LUZ M. MOYANO, MD; RICARDO GAMBOA, MSC; CLAUDIO MURO; PERCY VICHEZ, MSC (CYSTICERCOSIS ELIMINATION PROGRAM, TUMBES, PERU); SETH O´NEAL, MD, MPH (OREGON HEALTH AND SCIENCES UNIVERSITY, PORTLAND, USA); SUKWAN HANDALI, MD; JOHN NOH (CENTERS FOR DISEASE CONTROL, ATLANTA, USA); THEODORE E. NASH, MEDICO; SIDDHARTHA MAHANTY, MD, PHD (NIAID, NIH, BETHESDA, MD); JON FRIEDLAND (IMPERIAL COLLEGE, LONDON, UK). et al. Use of magnetic particles in the purification of IgM antibodies against Taenia solium. Rev. perú. med. exp. salud publica [online]. 2020, vol.37, n.1, pp.104-109. ISSN 1726-4634.